 |
Video: What is a Stock Split?
|
 |
Telesis Bio manufactures and sells laboratory equipment, synthetic biology instruments, reagents and associated products and related services to pharmaceutical and academic laboratories. Co.'s solutions include: BioXp 3250 and BioXp 9600 systems, which are an end-to-end automated workstation that enables researchers to go from a DNA sequence to endpoint-ready DNA; BioXp DBC, which is an enzymatic DNA synthesis with design to endpoint-ready synthetic RNA; BioXp portal, which is an online portal that provides guided workflow and design tools for building new DNA sequences; and BioXp De Novo kits, contain the building blocks and reagents for synthetic biology workflow applications. According to our TBIO split history records, TBIO has had 1 split. | |
 |

TBIO (TBIO) has 1 split in our TBIO split history database. The split for TBIO took place on May 09, 2024. This was a 1 for 18 reverse split, meaning for each 18 shares of TBIO owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 55.5555555555556 share position following the split.
When a company such as TBIO conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the TBIO split history from start to finish, an original position size of 1000 shares would have turned into 55.5555555555556 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into TBIO shares, starting with a $10,000 purchase of TBIO, presented on a split-history-adjusted basis factoring in the complete TBIO split history.

Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
06/21/2021 |
|
End date: |
02/10/2025 |
|
Start price/share: |
$358.92 |
|
End price/share: |
$0.35 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-99.90% |
|
Average Annual Total Return: |
-85.08% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$9.76 |
|
Years: |
3.64 |
|
|
 |
Date |
Ratio |
05/09/2024 | 1 for 18 |
|
 |